Drug Shortage Report for POTASSIUM ACETATE INJECTION USP
| Report ID | 172290 |
| Drug Identification Number | 02362597 |
| Brand name | POTASSIUM ACETATE INJECTION USP |
| Common or Proper name | Potassium Acetate Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM ACETATE |
| Strength(s) | 39.2% |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-10-31 |
| Actual start date | |
| Estimated end date | 2022-11-01 |
| Actual end date | 2022-11-01 |
| Shortage status | Resolved |
| Updated date | 2022-11-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-11-02 | English | Compare |
| v5 | 2022-11-01 | French | Compare |
| v4 | 2022-11-01 | English | Compare |
| v3 | 2022-11-01 | English | Compare |
| v2 | 2022-10-20 | French | Compare |
| v1 | 2022-10-20 | English | Compare |
Showing 1 to 6 of 6